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Radiotherapy continues to be a primary modality in the treatment of cancer. In addition to promoting apoptosis, radiation-induced DNA damage can promote autophagy and senescence, both of which can theoretically function to prolong tumor survival. In this work, we tested the hypothesis that autophagy and/or senescence could be permissive for DNA repair, thereby facilitating tumor cell recovery from radiation-induced growth arrest and/or cell death. In addition, studies were designed to elucidate the involvement of autophagy and senescence in radiosensitization by PARP inhibitors and the re-emergence of a proliferating tumor cell population. In the context of this work, the relationship between radiation-induced autophagy and senescence was also determined. Studies were performed using DNA repairproficient HCT116 colon carcinoma cells and a repairdeficient ligase IV -/-isogenic cell line. Exposure to radiation promoted a parallel induction of autophagy and senescence that was strongly correlated with the extent of persistent H2AX phosphorylation in both cell lines, however, inhibition of autophagy failed to suppress senescence, indicating that the two responses were dissociable. Exposure to radiation resulted in a transient arrest in the HCT116 cells while arrest was prolonged in the ligase IV -/-cells, however, both cell lines ultimately recovered proliferative function, which may reflect maintenance of DNA repair capacity. The PARP inhibitors, olaparib and niraparib, increased the extent of persistent DNA damage induced by radiation exposure as well as the extent of both autophagy and senescence. Neither cell line underwent significant apoptosis by radiation exposure alone or in the presence of the PARP inhibitors. Inhibition of autophagy failed to attenuate radiosensitization, indicating that autophagy was not involved in the action of the PARP inhibitors. As with radiation alone, despite sensitization by PARP inhibition, proliferative recovery was evident within a period of 10-20 days. While inhibition of DNA repair via PARP inhibition may initially sensitize tumor cells to radiation via the promotion of senescence, this strategy does not appear to interfere with proliferative recovery, which could ultimately contribute to disease recurrence. Ó 2016 by
INTRODUCTION
Radiotherapy is used along with other modalities such as surgery, chemotherapy and immunotherapy to either shrink tumors before surgery or eliminate surviving tumor cells after surgery. While ionizing radiation is ultimately cytotoxic by virtue of inducing DNA damage, specifically double-strand breaks (DSBs) (1) (2) (3) , radiation treatment also elicits a complex ensemble of responses that can moderate its toxic effects. Among these responses, autophagy and senescence are particularly intriguing because they can contribute to tumor control through autophagic cell death (4) or persistent growth arrest (5), respectively, but can also antagonize apoptosis and thereby shelter a population of dormant cells that may later reinitiate tumor regrowth (6) (7) (8) (9) .
There is extensive evidence that radiation can promote autophagy (10) . Autophagy can function as a pro-survival mechanism or as pro-death mechanism, depending on the agents used and the experimental systems. The relationship between autophagy and DNA repair is unclear, but several published studies have shown that autophagy might be involved in DNA repair in cells exposed to DNA-damaging agents (11) (12) (13) (14) (15) .
It is also well established that various forms of stress, particularly exposure to DNA-damaging agents such as radiation, can promote senescence (5, 16, 17) . While senescence has often been considered to be an irreversible form of growth arrest, it is long established that telomerase can be reactivated in cells undergoing replicative senes-cence, ultimately leading to an immortalized replicating cell population (18) . Furthermore, there is clear experimental evidence for reversibility of senescence under select experimental conditions (19) .
As for DNA damage and senescence it has been established that ionizing radiation induces DNA damage foci, the majority of which are transient and disappear within hours after treatment (20, 21) . While some foci may persist for months, the repair of DNA DSBs in senescent cells may result in recovery and regrowth. In fact, there is evidence that senescent cells can repopulate after exposure to chemotherapeutic agents and radiation (16, 19, (22) (23) (24) .
From a clinical perspective, the possibility of sensitization to radiation (and chemotherapy) through the administration of PARP inhibitors to interfere with DNA repair continues to be an area of active inquiry (25) (26) (27) (28) . Interestingly, radiosensitization has been shown to lead primarily to an increase in senescence with minimal apoptosis (29, 30) . Furthermore, the potential involvement of autophagy in radiation sensitization via PARP inhibition has not been investigated; this is relevant since it has been shown that autophagy and senescence may be closely associated responses in some studies (31) (32) (33) .
The primary goal of this work was to understand the involvement of autophagy and senescence in the response to radiation-induced DNA damage, and the interplay between these responses and DNA repair. Our findings revealed that the extent of both autophagy and senescence correlates with the intensity of persistent unrepaired DNA damage. Furthermore, interference with DNA repair via PARP inhibition using olaparib (AZD-2281) or niraparib (MK-4827) may initially sensitize cells via increased autophagy and senescence, but not apoptosis. However, this strategy does not appear to interfere with proliferative recovery, which could, in theory, contribute to disease recurrence (34) (35) (36) (37) .
MATERIALS AND METHODS

Cell Line
HCT116 colon cancer cells were purchased from ATCCt (Gaithersburg, MD) and HCT116 ligase IV-deficient cells were generated as previously described elsewhere (38) . HCT116 ligase IVdeficient and ligase IV-proficient cell lines were maintained as subconfluent cultures in RPMI 1640 media with 5% fetal bovine serum, 5% bovine calf serum, 2 mM L-glutamine and penicillin (Gibcot/Life Technologies, Gaithersburg, MD) and incubated at 378C, 5% CO 2 in a humidified environment. In every experiment, cells were cultured under identical conditions and incubated overnight to allow for adherence prior to irradiation.
ATG5 and ATG7 silencing shCon, shATG5 and shATG7 plasmid constructs were isolated (Plasmid Midi Kit; QIAGENt, Valencia, CA) using bacterial stocks (Sigma-Aldricht, St. Louis, MO). Plasmid constructs were packaged into lentiviral particles using HEK 239T cells and a packaging mixture composed of Lipofectaminet (cat. no. 11669-019; Invitrogene, Carlsbad, CA), psPAX2 and pMD2.G packaging constructs (nos. 12260, 12259; Addgene, Cambridge, MA). Growth media containing the viral particles was collected and used to infect HCT116 cells. Infected cells were then maintained with the selection marker, puromycin (2 lg/ml) throughout the course of the study.
Time Course of Radiation-Induced Effects on Cell Viability
Cells were plated in 6-well plates (generally 200,000 cells/well) and allowed to adhere overnight. The next day, cells were irradiated and the number of viable cells were counted at indicated time points for 5 days. In the case where a drug was co-administered (PARP inhibitors or autophagy inhibitors) with radiation treatment, cells were pretreated with the drug 3 h before irradiation and the drug was washed away 24 h postirradiation. In the case of the apoptosis inhibitor, Z-VAD-FMK, cells were pretreated for 3 h and maintained in the drug throughout the course of the study. At each time point, media was removed and cells were washed one time with 1X phosphate buffered saline (PBS). Trypsin (0.25%, 500 ll) was added to each well for harvesting and incubated for 5 min, then deactivated by 500 ll of fresh media to make up 1 ml of cell suspension. Cells were collected in 1 ml conical tubes (Eppendorf Inc., Westbury, NY) and 10 ll of cell suspension was added to 10 ll of trypan blue (0.4%), placed onto chamber slides of a hemocytometer (Hausser Scientific, Horsham, PA) and counted under a microscope.
Clonogenic Survival Assay
Cells (200) were plated in 6-well plates and allowed to adhere overnight. After 24 h, cells were pre-incubated with the indicated drug for 3 h and then exposed to the indicated dose of radiation. The following day, drug-containing media was removed, cells were washed and supplemented with fresh media that was replaced every other day for two weeks. On the day of staining, cells were fixed with 90% methanol for 10 min, and then stained with 1% crystal violet for another 10 min. Colonies were then washed with PBS three times to eliminate excessive crystal violet staining and counted manually.
Assessment of Autophagy by Acridine Orange Staining
Cells (50,000) were seeded in 6-well plates and allowed to adhere overnight, then exposed to radiation the following day. At the various time points, media was removed and cells washed once with 1X PBS. The acridine orange solution was made up in 1X PBS to a final concentration of 100 ng/ml in the dark and protected from light until ready for use. For flow cytometry, 10 ll of acridine orange solution was added to each sample and allowed to incubate for 15 min. Dyecontaining media was then aspirated, plates were washed with 1X PBS and fresh media was added. Photographs were taken with an Olympus 13 70 microscope and an Olympus SC 35 camera.
The cell population positively stained with acridine orange was quantified by flow cytometry. Treated cells were trypsinized, collected and centrifuged at 1,500 rpm for 5 min. Supernatant was removed and pellets were resuspended in 990 ll of 1X PBS. The cell suspension was filtered through a standard flow cytometry 40 micron filter (BD Falcone; BD Biosciences, Bedford, MA). The acridine orange solution was made up in 1X PBS to a final concentration of 100 ng/ml in the dark and protected from light until ready for use. For flow cytometry, 10 ll of acridine orange solution was added to each sample and allowed to mix for 15 min. Acridine orange is excited at a wavelength of 525 nM for green fluorescence and 620 nM for red fluorescence.
Transfection of HCT116 Cells with RFP-LC3
The RFP-LC3 construct was generated by the Tolkovosky laboratory (39) . HCT116 cells (1 3 10 6 ) were collected in a pellet, centrifuged and resuspended with the construct in 100 ll of the Amaxat Nucleofectore Kit V. One microgram of the RFP-LC3 vector was added to the suspension. The cell suspension was collected in a cuvette, then placed in nucleofector device to run program D-032. Media (500 ll) was added to the transfected cells and to transfer them to a petri dish where cells were maintained under gentamicin (8 ng/ml) to maintain the stable transfection.
Cell Cycle Analysis
At the indicated time points, cells were trypsinized, collected and centrifuged at 1,500 rpm. The supernatant was aspirated, pellets washed in PBS and recentrifuged at 1,500 rpm. The supernatant was removed, 0.2 ml of PBS was added and pellets were gently mixed to form a single cell suspension. Cold 70% ethanol (1.8 ml) was gradually added into the cell suspension; cells were vortexed, centrifuged, ethanol was aspirated and cells were washed with PBS prior to addition of a staining solution [0.1% (v/v) Tritone X-100 in 10 ml PBS, 2 mg of DNase free RNase A and 0.2 ml of the propidium iodide stock (1 mg/ml)] 2 h prior to flow cytometry.
Evaluation of Senescence by b-Galactosidase Staining
Beta-galactosidase staining was utilized as a marker of senescence. Cells were washed once with 1X PBS and fixed with 2% formaldehyde/ 0.2% glutaraldehyde for 5 min, washed again with PBS and finally incubated overnight in a staining solution composed of 1 mg/ml 5-bromo-4-chloro-3-indolyl-b-galactosidase in dimethylformamide (20 mg/ml stock), 5 mM potassium ferricyanide, 150 mM NaCl, 40 mM citric acid/ sodium phosphate, 2 mM MgCl2, at pH 6.0 in CO2 at 378C. The following day, cells were washed twice with PBS and images were taken.
For b-galactosidase detection by flow cytometry, cells were washed and incubated for 1 h in complete media containing 100 nM of bafilomycin A1 to induce lysosomal alkalinization. After incubation, C 12 FDG working solution was added to each well for a final concentration of 33 lM, and incubation was continued for another 1 h. Media was then aspirated and cells were washed twice with PBS. Cells were harvested, collected by centrifugation at 1,500 rpm, resuspended in PBS and analyzed by flow cytometry, as described above, but with excitation at 490 nm and a 514 nm emission filter. C 12 FDG is hydrolyzed by upregulated b-galactosidase enzyme and becomes fluorescent at a wavelength of 500-510 nM.
Determination of c-H2AX Intensity as a Marker of DNA Damage Cells (5,000) were seeded in 4-chamber cover glass slides (LabTeke II) and allowed to adhere overnight. On the following day, cells were irradiated and fixed with 4% formaldehyde for 5 min at indicated time points. Cells were washed twice with 1X PBS, incubated at room temperature in 0.05% Triton X for 15 min, washed and incubated with 1X PBS containing 1% of BSA for 30 min to prevent nonspecific binding of the antibody. Finally, cells were incubated in a 1:10 dilution of c-H2AX antibody (BD Pharmingene, San Diego, CA) in 1% BSA for 1 h. Images were taken using an LSM 700 confocal microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY).
Alternatively, for flow cytometry, cells were harvested at the indicated time points, fixed with 90% ethanol and maintained at À208C until the day of the experiment. Cells were then centrifuged at 3,000 rpm for 5 min and resuspended in 1% BSA for 30 min. Gamma-H2AX antibody (BD Pharmingen) was added to the cells in a dilution of (1:200) and incubated at room temperature for 1 h. Cells were then analyzed by flow cytometry at an excitation wavelength of 488. Raw data were normalized according to the intensity of control samples (normalized mean intensity ¼ intensity of the sample/the intensity of the corresponding control sample within the same experiment).
Evaluation of DNA Damage Extent by the Comet Assay
Cells (200,000) were plated in 6 cm dishes and treated as indicated. After 72 h, cells were gently scraped from the plates and 100,000 cells were mixed with molten LMAgarose (at 378C) at a ratio of 1:10 (v/v). The mixture of cells and LMAgarose was then pipetted onto CometSlidese (Trevigent Inc., Gaithersburg, MD) and incubated for 30 min at 378C. The slides were kept at 48C for 10 min prior to being immersed in Lysis Solution (Trevigen) overnight. On the following day, the slides were immersed in 1X neutral electrophoresis buffer for 30 min at 48C, set onto an electrophoresis tray for 45 min and electrophoresed at 1 volt per cm. Slides were then immersed in DNA precipitation solution (1 M ammonium acetate in 70% ethanol) for 30 min at room temperature, followed by 70% ethanol for another 30 min. Samples were dried at 378C for 30 min and stained with the working dilution of SYBRt Green (Trevigen).
Evaluation of Apoptosis
After the indicated treatments, cells were harvested at the indicated time points and collected on a cytospin slide, fixed with formaldehyde (4%) for 5 min and washed with 1X PBS twice. Slides were fixed with acetic acid/ ethanol (1:2) for 5 min and washed twice with 1X PBS. For the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, cells were blocked with BSA (1 mg/ml for 30 min) at room temperature, washed twice in PBS and incubated with enzyme mixture (terminal transferase, 25 mM CoCl 2 , fluorescein-12dUTP) for 1 h at 378 to allow the enzymatic reaction. After washing with PBS, cells were stained with DAPI and images were taken using a fluorescence microscope.
For the PI/Annexin assay, adherent and non-adherent cells were harvested in Eppendorf tubes and pellets resuspended in 100 ll of binding buffer (BD Biosciences). Annexin-FITC (5 ll; BD Biosciences) and 5 ll of PI at 10 lg/ml (BD Biosciences) were added to the cell suspension and incubated for 15 min in the dark at room temperature. Annexin V binding buffer 1X (400 ll; BD Pharmingen) was added to each sample and samples were analyzed by flow cytometry at 530 nM.
Western Blotting
At the indicated time points, cells were harvested and mixed with lysis buffer (1 M Tris HCl, pH 6.8, 10% SDS) containing protease and phosphatase inhibitors (Sigma-Aldrich). Proteins were separated on 12% gels using SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were blocked using nonfat dry milk and PBS for 30 min at room temperature, then incubated with the primary antibody overnight at 48C. Primary antibodies used were as follows: anti-p62 (SQSTM1, cat. no. sc-28359; Santa Cruz Biotechnologyt, Inc., Dallas, TX), anti-b actin (cat. no. sc-47778; Santa Cruz), anti-ATG5 (cat. no. 12994S; Cell Signaling Technologyt, Danvers, MA), and anti-ATG7 (cat. no. 8558S; Cell Signaling). All primary antibodies were used at a 1:1,000 dilution. The following day, membranes were incubated with correspondent secondary antibodies for 1 h. Secondary antibodies used were goat anti-mouse IgG (Amersham, GE Healthcare Bio-Sciences, Pittsburgh, PA) and monkey anti-rabbit IgG (Amersham, GE Healthcare). Membranes were then washed three times and bands were detected using enhanced chemiluminescence detection reagents (Piercee Biotechnology, Rockford, IL).
Statistical Analysis
Statistical analyses were performed using StatView statistical software (SAS Institute Inc., Cary, NC). The data were expressed as means 6 SE. Comparisons were made using two-way analysis of variance followed by the Bonferroni post hoc test. P values ,0.05 were considered statistically significant.
RESULTS
Response of DNA Repair-Competent and DNA RepairDeficient Cell Lines to Radiation Exposure
Radiation sensitivity in the HCT116 and the HCT116 ligase IV-deficient cell lines was determined by clonogenic Figure 1A shows that HCT116 cells lacking ligase IV were significantly more sensitive to radiation than the ligase IV wild-type cells, as the clonogenic survival was significantly decreased at lower doses of radiation compared to wild-type cells. This finding is consistent with previously published literature indicating that DNA repair-deficient cell lines are more sensitive to radiation than DNA repairproficient cells (40) (41) (42) .
Radiation sensitivity was further compared by performing temporal response studies in which the HCT116 and the HCT116 ligase IV-deficient cell lines were irradiated (2 Gy) and viable cell number was monitored over time. Figure 1B shows that growth of the irradiated HCT116 cells was inhibited only transiently followed by relatively rapid recovery of proliferative capacity, whereas in the irradiated HCT116 ligase IV-deficient cells, a sustained growth inhibition was observed (with a slight decline in viable cell number between day 3 and 5).
The difference in radiosensitivity of the two cell lines is likely to be a consequence of the extent and persistence of DNA damage (42, 43) . Figure 1C (staining with c-H2AX antibody) and D (H2AX phosphorylation) indicate that the number of DNA damage foci in HCT116 ligase IV -/-cells was increased compared to the ligase IV-proficient cells. That is, over a range of radiation doses, the extent of residual damage (i.e., c-H2AX staining) at 96 h was significantly higher in the ligase IV-deficient HCT116 cells than in the ligase IV-proficient cells.
As additional confirmation of the increased DNA damage, results of comet assay experiments (Fig. 1E) show more extensive formation of tails after low-dose irradiation (2 Gy) in the HCT116 ligase IV -/-cells compared to the HCT116 wild-type cells. Furthermore, cell cycle analyses indicated that 72 h after a 2 Gy dose, nearly 45% of the HCT116 ligase IV -/-cells were arrested at the G 2 /M phase compared to 20% of the HCT116 wild-type cells (Fig. 1F) .
Induction of Autophagy and Senescence by Ionizing Radiation Exposure in Ligase IV-Proficient HCT116 and Ligase IV-Deficient HCT116 Cell Lines
We and others have reported that a primary response of tumor cells to radiation is autophagy (44) (45) (46) (47) . Figure 2A shows images of irradiated cells stained with acridine orange, which is indicative of autophagy, while Fig. 2B provides quantification of the extent of autophagy over a range of radiation doses. While the extent of autophagy was significantly greater in the ligase IV-deficient cells compared to parental cells at lower doses of radiation, essentially the entire cell population had entered a state of autophagy for both cell lines at the higher doses.
As senescence has been closely associated with autophagy in a number of published studies (31, 48) , the induction of senescence by radiation exposure was also monitored. Both cell lines demonstrated physiological markers of senescence such as granulation, flattening and spreading, as well as b-galactosidase staining, a hallmark of senescence (Fig. 2C) . In parallel to the findings relating to autophagy, senescence was more pronounced in the ligase IV-deficient cells compared to the ligase IV-proficient cells at the lower radiation doses, while higher doses yielded maximal senescent populations in both cell lines (Fig. 2D) .
Although radiation-induced autophagy, senescence and persistent H2AX phosphorylation were greater in the HCT116 ligase IV-deficient cells than in ligase IVproficient cells at the lower radiation doses, the fraction of cells showing autophagy and senescence, at any given level of c-H2AX, was very similar for the two cell lines (Supplementary Fig. S1A and B; http://dx.doi.org/10. 1667/RR14202.1.S1). Supplementary Fig. S1C also indicates a direct correspondence between the extent of autophagy and senescence (as a function of the radiation dose) in both HCT116 tumor cell lines. Thus, both senescence and autophagy correlate with, and are likely triggered by, persistent DSBs.
The Relationship between Autophagy and Senescence in Irradiated Cells
Our studies are indicative of a close correspondence between radiation-induced autophagy and senescence in both the ligase IV-deficient and the ligase IV-proficient cell lines (Supplementary Fig. S1C ; http://dx.doi.org/10.1667/ RR14202.1.S1), which is also the case for oncogene and chemotherapy-induced autophagy and senescence (31, 48) . To more rigorously investigate the potential association between autophagy and senescence in response to radiation exposure, both cell lines were either pre-incubated with the pharmacological inhibitors of autophagy, chloroquine (5 lM) and bafilomycin (5 nM), for 3 h prior to irradiation, or infected with lentivirus to induce a knockdown of the essential autophagy factors, ATG5 and ATG7. (Supplementary Fig.  S2A ). Supplementary Fig. S2B and C confirm that autophagy has been inhibited by chloroquine and bafilomycin in both cell lines based on the interference with radiation-induced degradation of p62/SQSTM1. Similarly, Supplementary Fig.  S2D and E confirm that autophagy has been inhibited by the genetic silencing approaches. Figure 3 indicates that pharmacological and genetic inhibition of autophagy had no effect on the promotion of radiation-induced senescence in these cell lines, as the extent of senescence was essentially identical in the absence and presence of functional autophagy, strongly We have shown proliferative recovery after induction of senescence by radiation exposure as well as doxorubicin in breast tumor cells (16, 31, 44, 47) . The HCT116 ligase IVproficient and HCT116 ligase IV-deficient cells were exposed to radiation doses of 6 Gy and 3 Gy, respectively; cells were sorted based on staining with the senescence marker, C 12 FDG, 96 h postirradiation by flow cytometry (Fig. 4A and B) . Both subpopulations (i.e., positively stained and negatively stained cells) were replated at subconfluent density. Figure 4C confirms that recovery occurs after radiation-induced autophagy and senescence in both the HCT116 ligase IV-proficient and ligase IV-deficient cells. These findings are consistent with studies where proliferative recovery was observed after irradiation of MCF-7 breast tumor cells (16, 44) .
The capacity for proliferative recovery suggests that DNA repair is likely to be functional in the autophagy/senescent cells. To address this possibility, HCT116 cells were exposed to a dose of radiation (8 Gy) that induces ;75% of both autophagy and senescence; the cells were then allowed to undergo repair for 4 days, followed by reirradiation with 4 Gy. Repair intensity was measured after 30 min, 3 h, 24 h and 4 days based on c-H2AX intensity determined by flow cytometry. Four days after the first irradiation (8 Gy), the level of c-H2AX remained high. At the second irradiation (4 Gy), the intensity of c-H2AX was further elevated for 3 h. However, the intensity of c-H2AX was reduced by 24 and 96 h after the second dose, suggesting that, despite the persistence of initial DNA damage, these cells were still generally proficient in DNA repair capacity (Fig. 4D, left-side panel) .
Similarly, HCT116 ligase IV -/-cells were initially irradiated with 4 Gy, a dose that induces ;75% of senescence and autophagy, followed four days later by 2 Gy irradiation. Figure 4D , right-side panel, indicates that even these ostensibly repair-incompetent cells show the capacity to repair the newly induced DNA damage.
Radiosensitization by PARP Inhibitors Correlates with Increased Autophagy and Senescence, but Not Apoptosis
There has been a great deal of interest in utilizing DNA repair inhibitors in combination with chemotherapeutic drugs and radiation to enhance the efficacy of cancer therapy. In the context of this work, it has been reported that radiosensitization by PARP inhibitors is accompanied by increased senescence (29, 30, 49) . Given the evidence for correspondence between autophagy and senescence in the current work, we proceeded to investigate whether sensitization by PARP inhibitors could be mediated through the promotion of autophagy as well as senescence. Two different PARP inhibitors, AZD-2281 (olaparib) and MK-4827 (niraparib), were utilized to investigate whether the PARP inhibitors could sensitize both ligase IV-deficient cells and ligase IV-proficient HCT116 cells to radiation. Figure 5A shows that PARP inhibitors conferred profound radiation sensitization in the ligase IV-proficient HCT116 cells. However, while ligase IVdeficient cells were also sensitized, the degree of sensitization was clearly less than in the ligase IV-proficient cells. Temporal response data (Fig. 5B ) also showed a more pronounced radiosensitization in the ligase IV-proficient cells than in the ligase IV-deficient cell lines when equitoxic doses of radiation were used. As expected, this sensitization was associated with an increase in DNA damage based on the intensity of c-H2AX formation (Fig. 5C ) and the increased DNA content in the comet tails by the comet assay (Supplementary Fig. S3A and B; http://dx.doi.org/10.1667/RR14202.1.S1).
Sensitization to radiation by the PARP inhibitors is also associated with an increase in senescence. Quantification of the intensity of b-galactosidase staining by flow cytometry indicated that between 55-60% of the ligase IV-proficient HCT116 cells had entered a state of senescence when the PARP inhibitors were used in combination with radiation, whereas radiation treatment alone induced ;20% senescence (Fig. 5D , left-side panel and Supplementary Fig. S3C) . Similarly, the HCT116 ligase IV-deficient cells showed an increase in the senescent population from less than 20% to between 45-55% when the PARP inhibitor was administered along with radiation treatment (Fig. 5D , right-side panel, and Supplementary Fig. S3D ). Consistent with the increased senescence, cell cycle analysis results demonstrated that ; 45% of the population in both cell lines underwent growth arrest at the G 2 /M phase when cells were treated with the combination compared to ;20% when cells were exposed to radiation alone (Supplementary Fig. S3E ).
The combined treatment of AZD-2281 or MK-4827 with radiation also resulted in increased autophagy. Quantification of the intensity of autophagy by flow cytometry showed an increase in the number of autophagic cells to 70-80% of the population for the combination treatment in the ligase IV-proficient cells, whereas radiation alone promoted approximately 30% autophagy (Fig. 5E , left-side panel, and Supplementary Fig. S4A and B; http://dx.doi.org/10.1667/ RR14202.1.S1). Similarly, the HCT116 ligase IV-deficient cells showed an increase in the autophagic population to 75% when the PARP inhibitor was administered along with radiation compared to 35% when exposed to radiation alone (Fig. 5E , right-side panel and Supplementary Fig. S4C) .
Overall, the PARP inhibitors appear to produce comparable enhancement of H2AX phosphorylation, autophagy and senescence in wild-type and ligase IV-deficient cells, but less radiosensitization of ligase IV-deficient cells, particularly as measured by clonogenic survival.
Although co-treatment with PARP inhibitors enhanced the radiosensitivity of ligase IV proficient HCT116 cells and HCT116 ligase IV-deficient cells, it was critical to determine whether the cells would retain their proliferative recovery after the combination treatment by monitoring cell viability over an extended period after treatment. Figure 6 demonstrates that both cell lines recovered proliferative capacity on day 10, 15 and 20 after treatment when radiation was combined with the PARP inhibitors.
Lack of Involvement of Apoptosis in Sensitization by PARP Inhibitors in HCT116 Cells
Use of PARP inhibitors has generally been shown to radiosensitize cells through the induction of senescence, but not apoptosis (30, 49) . To rule out the potential involvement of apoptosis in radiosensitization, apoptotic cell death was monitored by Annexin V staining. Supplementary Fig. S5A (http://dx.doi.org/10.1667/RR14202.1.S1) indicates that apoptosis is unlikely to be involved in radiosensitization of both cell lines by PARP inhibition as apoptosis was minimal and not increased by the PARP inhibitors. The minimal involvement of apoptosis in radiosensitization by PARP inhibition was confirmed by assessment of apoptosis 72 h after treatment using the TUNEL assay ( Supplementary Fig. S5B and C) . To further confirm these results, irradiated HCT116 cells were treated with the pan-caspase inhibitor Z-VAD-FMK (10 lM) and viable cell numbers were monitored over five days. Supplementary Fig. S5D shows that interference with apoptosis via inhibition of caspases did not interfere with radiosensitization by the PARP inhibitors, indicating that apoptosis does not appear to be involved in mediating the observed effects. Consistent with these observations, cell cycle analysis demonstrated that administering PARP inhibitors along with radiation does not increase the sub-G 1 population (data not shown), confirming that apoptosis is not occurring in cells exposed to radiation þ PARP inhibitors.
Effects of Autophagy Inhibition on Radiosensitization by PARP Inhibition
Our study clearly shows that autophagy was increased in association with senescence when PARP inhibitors were used in combination with radiation. Several published studies, including our own, have demonstrated that autophagy can act as a cytotoxic or cytostatic process through which cells die or undergo prolonged growth arrest (44, 46, 47, 50) . To address whether inhibition of autophagy would interfere with the radiosensitization by PARP inhibitors, HCT116 cell lines where autophagy was genetically silenced or pretreated with chloroquine were exposed to radiation in the absence and presence of the PARP inhibitors. Figure 7A -F shows that genetic interference with autophagy does not rescue either of the HCT116 cell lines from radiosensitization by PARP inhibition. These findings are supported by the data shown in Supplementary Fig. S6 (http://dx.doi.org/10.1667/RR14202. 1.S1) where the autophagy inhibitor, chloroquine, also failed to interfere with radiosensitization by the PARP inhibitors in HCT116 cells as well as H460 non-small cell lung cancer cells, indicating that radiosensitization does not occur via the promotion of autophagy.
DISCUSSION
DNA Damage, Autophagy and Senescence Induced by Radiation
Although radiotherapy is one of the most widely used cancer therapies, its effectiveness may vary widely according to tumor type. For example, radiotherapy significantly reduces recurrence and improves outcomes in breast and head and neck cancer, respectively (51, 52) , but is less effective in the treatment of glioblastoma and lung cancer (53) (54) (55) . Consequently, decades of preclinical efforts have been devoted to the development of strategies to sensitize malignancies to radiation therapy.
While it is generally agreed that radiation kills tumor cells by generating DSBs, these breaks as well as other DNA damage elicit a complex cascade of responses that can influence the repair and persistence of DNA damage as well as the consequences of unrepaired damage, factors that together determine whether or not an irradiated tumor cell will ultimately resume proliferation. Among these responses, radiation can induce cells to enter states of senescence as well as autophagy (5, 56) . Because autophagy can function FIG. 7 . Inhibition of autophagy does not alter radiosensitization by PARP inhibition. Autophagy-regulated genes were silenced in the HCT116 wild-type and HCT116 ligase IV-deficient cell lines using short hairpin RNA (shRNA) for ATG5 and ATG7. Panels A-C: Autophagy-proficient HCT116 cells were irradiated with and without exposure to PARP inhibitors. Panels D-F: Autophagy-deficient HCT116 ligase IV cells were irradiated with and without exposure to PARP inhibitors.
as either a pro-survival or pro-death mechanism (57, 58) , depending on the agents used and the experimental systems, it provides an especially attractive target for pharmacological manipulations that could selectively increase radiosensitivity of tumor cells but not normal cells.
The relationship between autophagy and DNA repair is unclear, but autophagy can alter the cellular response to DNA damaging agents. Disruption of autophagy by bafilomycin A1, an autophagy inhibitor, sensitized glioma cells to the alkylating agent telmozolomide by inducing apoptosis (11) . Similarly, 6-thioguanine-induced autophagy enhanced the survival of human colorectal and endometrial cells, indicating in both studies that autophagy may play a protective role against DNA damage (12). Robert et al. recently reported on their findings that autophagy and protein acetylation are important in DNA damage repair via activation of cell cycle check points, influencing homologous recombination repair (HRR) (13) . Another published study has shown that PARP-1 might link DNA damage to autophagy through the depletion of ATP and NAD þ , which may indicate that a cytoprotective function of autophagy was promoted to supply the cell with energy (14) . Interference with autophagy by knocking out FIP200, an essential player in mammalian autophagy, resulted in impaired DNA repair in mouse embryonic fibroblasts treated with DNA damaging agents (15) . On the other hand, human malignant glioma cells undergo autophagic cell death upon inhibition of the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a protein involved in non-homologous end joining (NHEJ) (59) . In related studies, inhibition of DNA-PKcs was found to radiosensitize radioresistant prostate cancer cells by inducing autophagy (60) . It therefore appears likely that autophagy has an important function in the enhancement of DNA repair in cells during exposure to genotoxic stress, but that the role of autophagy may differ according to the status of DNA repair.
Senescence is also induced upon exposure to a DNAdamaging agent such as radiation (16, 17, 56) . Moreover, similar to the telomere-associated foci of replicative senescence, radiation-induced senescence is associated with persistent DNA damage foci (61, 62) , presumably unrepaired DSBs that can remain for months and may be essential for maintaining the long-term growth arrest that characterizes the senescent cell.
In this work, we sought to identify whether autophagy and senescence play major roles in either facilitating or antagonizing DNA repair, using two isogenic cell lines, HCT116 and HCT116 ligase IV -/-cells. The ligase IV mutation completely inactivates repair of DSBs by classical NHEJ (63) . Thus, as expected, at 1-2 Gy irradiation, the ligase IV-deficient cell line demonstrated lower survival than parental cells and higher levels of persistent c-H2AX foci. At each dose of radiation this increased damage was accompanied by higher levels of both senescence and autophagy than in parental cells. Moreover, when senescence or autophagy were plotted as a function of c-H2AX intensity at 96 h postirradiation, the plots for the two cell lines were very similar. Thus, autophagy and senescence appear to correlate with the level of persistent DSBs, suggesting that the persistent breaks and associated repair foci are primarily responsible for promoting and sustaining both senescence and autophagy. These data are consistent with studies showing that DNA damage can also induce cells to undergo a state of senescence associated with autophagy (31) .
Relationship between Radiation-Induced Autophagy and Senescence
As we observed a direct correlation between the fractions of autophagic and of senescent cells in response to DNA damage in both cell lines, it was noteworthy to determine whether the functions of autophagy and senescence were interlinked. The relationship between autophagy and senescence is still debatable. While the induction of senescence has been reported to be, at least in part, dependent on autophagy (31, 48) , other studies have concluded that senescence is independent of autophagy (64, 65) . Despite the close correspondence between autophagy and senescence in parental and ligase IV -/-HCT116 cells, pharmacological and genetic inhibition of autophagy did not seem to affect the promotion of senescence even at high doses of radiation, indicating that promotion of senescence is independent of autophagy in this experimental model.
Effect of PARP Inhibition on Radiation Sensitivity, Autophagy and Senescence
Given the observation that irradiated cells appear to undergo proliferative recovery after a period of growth arrest, we sought to sensitize both cell lines to radiation by interfering with DNA repair to combat the recovery. PARP inhibitors are considered one of the promising radiosensitizing agents that have been tested in clinical trials (66) (67) (68) (69) (70) (71) . The poly (ADP-ribose) polymerase (PARP) enzyme is involved in repair of single-strand breaks (SSBs), and lack of this enzyme in knockout mice enhanced sensitivity to radiation and alkylating agents (72) . PARP inhibition converts SSBs to DSBs, which in turn leads to the activation of HRR (73) . In cells lacking the BRCA1 protein, which is a critical component of the HRR pathway, PARP inhibition can be lethal even in the absence of exogenous DNA damaging agents (74) . Due to microsatellite instability in colorectal cancer cells, the expression of MRE11, another protein involved in the HRR pathway, is reduced (75) . Thus, co-administration of PARP inhibitors with radiation was anticipated to lead to radiosensitization in HCT116 cells.
PARP inhibitors increased the intensity of c-H2AX and the number of irradiated cells undergoing autophagy and senescence, but not apoptosis. These data were consistent with our findings that both autophagy and senescence are directly correlated with induced DNA damage. In parental HCT116 cells, this increased DNA damage was associated with a dramatic reduction in clonogenic survival of irradiated cells, especially with MK-4827. Radiosensitization of the already radiosensitive ligase IV-deficient cells was less robust, despite similarly elevated levels of c-H2AX, autophagy and senescence. This result is consistent with a model wherein radiosensitization results at least in part from inappropriate channeling of replication-associated one-sided DSBs into NHEJ; thus, when NHEJ is absent, radiosensitization is diminished. This mechanism has been invoked previously to explain the similar dependence of PARP inhibitor sensitivity on the absence of NHEJ in BRCA1-deficient cells (76) , except that in those cells the initial SSBs would be spontaneous rather than radiation induced. In contrast to our results, a previous study reported that ligase IV-deficient mouse fibroblasts were radiosensitized by a PARP inhibitor (olaparib) at least as much as wild-type cells, and in that case radiosensitization was attributed to inhibition of a backup or ''alternative'' (Alt-NHEJ) pathway that is PARP-dependent and ligase IVindependent (77). Intriguingly, however, those ligase IV -/-cells, but not the normal cells, were also p53 -/-due to the inviability of p53 þ/þ ligase IV -/-mice, whereas HCT116 and its derivatives are p53 þ/þ . An alternative explanation for the relative lack of sensitization of the ligase IV -/-HCT116 cells is that these cells, after extended propagation in culture, have acquired upregulated HRR or Alt-NHEJ functions (78) , rendering these repair systems less susceptible to PARP inhibitors.
In any case, apoptosis does not appear to be involved in the cytotoxicity of combination therapy in either cell line, indicating that the radiosensitization of these cell lines by PARP inhibitors might be mediated by promoting autophagy and senescence. Interestingly, inhibition of autophagy also did not interfere with PARP inhibitor-mediated radiosensitization, as judged by the temporal response assay. Taking into the consideration that radiation-induced senescence and radiation-induced autophagy are not linked in our system, these findings support the premise that radiosensitization is likely to be occurring via the promotion of senescence.
A recently published study showed that PARP-1 is involved in a newly identified backup pathway named PARP1-dependent end joining (PARP1-EJ) (79) . This new finding adds another aspect of the lethality of our combination therapy in HCT116 cell lines when main repair pathways are blocked, i.e., it could account for the residual radiosensitizing effect of PARP inhibitors in the cells that lack ligase IV. However, another NHEJ-like backup repair mechanism, called the mutagenic NHEJ pathway or A-NHEJ, can be activated when PARP1-mediated and HR pathways are inactivated (80) .
The relationship among DNA damage, autophagy and senescence is likely to be quite complex and our goals were primarily to establish whether sensitization through PARP inhibitors could occur through senescence, as postulated by the Weichselbaum group (30, 49) , whether the senescence might be dependent on autophagy and whether autophagy might also play a role in sensitization. Our studies rule out the involvement of autophagy in the radiosensitization and furthermore dissociate radiation-induced autophagy from senescence. With regard to mechanistic questions, it has been demonstrated that DNA damage can lead to senescence and autophagy, possibly via induction of ATM. The upregulation of ATM leads to the activation of its downstream target p53, which then promotes senescence via the p21-pRb pathway (81, 82) . Also, p53 can activate the autophagy promoter AMP-activated protein kinase during the genotoxic stress, which in turn phosphorylates tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 (83) (84) (85) . Both the TSC1 and TSC2 proteins downregulate mTOR, which eventually leads to the promotion of autophagy (86, 87) . It is worth mentioning that HCT116 cells have a frameshift mutation in p16 (88) , however, a number of published studies, including this current study, have indicated that senescence could be upregulated in a p16-independent manner (5, 89, 90) . Our data suggest that a persistent DNA damage response may upregulate ATM and induce p53. It is possible that the autophagy/senescence pathways diverge at p53 wherein for senescence the pathway could involve the sequence of p53-p21-pRb, whereas in autophagy the pathway may reflect actions at the level of p53-AMPK-TSC-mTOR. We anticipate that future studies will address these questions.
Conclusions
There is no consensus as to whether radiation-induced senescence or chemotherapy is reversible (19, 22-24, 91, 92) . We demonstrate, both in the case of radiation treatment alone and in the studies combining PARP inhibition with radiation treatment, that growth arrest is followed by proliferative recovery. In this context, the studies by Chitkova et al. in an apoptosis-deficient cell line (93) support our findings that senescence may be reversible. These observations clearly suggest that tumor cells entering a state of autophagy/senescence have the capacity to reemerge into a proliferative state. If these findings can be extrapolated to clinical cancer, this may explain why radiation treatment is not fully effective for some types of malignancies. Furthermore, it is likely that the use of PARP inhibitors will result in only transient radiosensitization.
We conclude that the extent of radiation-induced DNA damage is accompanied by an increase of autophagy and senescence. The extent of autophagy and senescence induced at different doses of radiation was more pronounced in the ligase IV-deficient cells, which is correlated with increased levels of DNA damage. Autophagic/senescent HCT116 cells demonstrated the ability to repair the newly formed DSBs. These data may indicate that promoting senescence alone would not have an effect on overall DNA repair system efficiency, which may explain why even the radiosensitized cells ultimately recover proliferative capacity. Current therapeutic regimens such as radiotherapy generally fail to completely eradicate the tumor cell population. This could be due, in part, to the induction of autophagy and senescence, which may be permissive for DNA repair as well as proliferative recovery that occurs even with the inclusion of PARP inhibitors, which may therefore not interfere with disease recurrence. Fig. S1 . Relationship between autophagy, senescence and DNA damage. 
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